A detailed history of Psi Advisors, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Psi Advisors, LLC holds 1 shares of OCGN stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 21, 2023

BUY
$0.45 - $0.88 $0 - $0
1 New
1 $0
Q2 2022

Jul 18, 2022

SELL
$1.83 - $3.45 $2,452 - $4,623
-1,340 Reduced 67.34%
650 $1,000
Q4 2021

Feb 11, 2022

SELL
$4.38 - $15.67 $262 - $940
-60 Reduced 2.93%
1,990 $9,000
Q3 2021

Nov 12, 2021

BUY
$6.36 - $8.51 $13,038 - $17,445
2,050 New
2,050 $15,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $206M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Psi Advisors, LLC Portfolio

Follow Psi Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Psi Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Psi Advisors, LLC with notifications on news.